These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9526146)

  • 21. Nigrostriatal and Mesolimbic D
    Stark AJ; Smith CT; Lin YC; Petersen KJ; Trujillo P; van Wouwe NC; Kang H; Donahue MJ; Kessler RM; Zald DH; Claassen DO
    J Neurosci; 2018 Mar; 38(13):3230-3239. PubMed ID: 29483278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson's disease.
    Maillet A; Krack P; Lhommée E; Météreau E; Klinger H; Favre E; Le Bars D; Schmitt E; Bichon A; Pelissier P; Fraix V; Castrioto A; Sgambato-Faure V; Broussolle E; Tremblay L; Thobois S
    Brain; 2016 Sep; 139(Pt 9):2486-502. PubMed ID: 27538418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Selective Role for Dopamine in Learning to Maximize Reward But Not to Minimize Effort: Evidence from Patients with Parkinson's Disease.
    Skvortsova V; Degos B; Welter ML; Vidailhet M; Pessiglione M
    J Neurosci; 2017 Jun; 37(25):6087-6097. PubMed ID: 28539420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The dopamine transporter: importance in Parkinson's disease.
    Nutt JG; Carter JH; Sexton GJ
    Ann Neurol; 2004 Jun; 55(6):766-73. PubMed ID: 15174010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. False-Positive DaTscan Features With Methylphenidate and Phentermine Therapy.
    Huynh KN; Nguyen BD
    Mayo Clin Proc; 2018 Nov; 93(11):1690-1691. PubMed ID: 30392555
    [No Abstract]   [Full Text] [Related]  

  • 26. Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion, and triazolam in d-amphetamine-trained humans.
    Rush CR; Kollins SH; Pazzaglia PJ
    Exp Clin Psychopharmacol; 1998 Feb; 6(1):32-44. PubMed ID: 9526144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Actions of methylphenidate on dopaminergic neurons of the ventral midbrain.
    Federici M; Geracitano R; Bernardi G; Mercuri NB
    Biol Psychiatry; 2005 Feb; 57(4):361-5. PubMed ID: 15705351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improvement of facial affect recognition in children and adolescents with attention-deficit/hyperactivity disorder under methylphenidate.
    Beyer von Morgenstern S; Becker I; Sinzig J
    Acta Neuropsychiatr; 2014 Aug; 26(4):202-8. PubMed ID: 25142287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "Nonhedonic" food motivation in humans involves dopamine in the dorsal striatum and methylphenidate amplifies this effect.
    Volkow ND; Wang GJ; Fowler JS; Logan J; Jayne M; Franceschi D; Wong C; Gatley SJ; Gifford AN; Ding YS; Pappas N
    Synapse; 2002 Jun; 44(3):175-80. PubMed ID: 11954049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Depressive pseudodementia in early Parkinson's disease: lessons from a case with long-term follow-up].
    Giménez-Roldán S; Mateo D; Dobato JL
    Neurologia; 1997 Mar; 12(3):130-5. PubMed ID: 9198454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular effects of methylphenidate in humans are associated with increases of dopamine in brain and of epinephrine in plasma.
    Volkow ND; Wang GJ; Fowler JS; Molina PE; Logan J; Gatley SJ; Gifford A; Ding YS; Wong C; Pappas NR; Zhu W; Swanson JM
    Psychopharmacology (Berl); 2003 Mar; 166(3):264-70. PubMed ID: 12589522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Placebo neural systems: nitric oxide, morphine and the dopamine brain reward and motivation circuitries.
    Fricchione G; Stefano GB
    Med Sci Monit; 2005 May; 11(5):MS54-65. PubMed ID: 15874901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ventral Tegmental Area Dopamine Cell Activation during Male Rat Sexual Behavior Regulates Neuroplasticity and d-Amphetamine Cross-Sensitization following Sex Abstinence.
    Beloate LN; Omrani A; Adan RA; Webb IC; Coolen LM
    J Neurosci; 2016 Sep; 36(38):9949-61. PubMed ID: 27656032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease.
    Meco G; Bernardi S
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):311-3. PubMed ID: 16919377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mood changes associated with "end-of-dose deterioration" in Parkinson's disease: a controlled study.
    Cantello R; Gilli M; Riccio A; Bergamasco B
    J Neurol Neurosurg Psychiatry; 1986 Oct; 49(10):1182-90. PubMed ID: 3783180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methylphenidate increases the motor effects of L-Dopa in Parkinson's disease: a pilot study.
    Camicioli R; Lea E; Nutt JG; Sexton G; Oken BS
    Clin Neuropharmacol; 2001; 24(4):208-13. PubMed ID: 11479391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of atomoxetine and methylphenidate on the prepulse inhibition of the acoustic startle response in mice.
    Woo H; Park SJ; Lee Y; Kwon G; Gao Q; Lee HE; Ahn YJ; Shin CY; Cheong JH; Ryu JH
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():206-15. PubMed ID: 24953433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measurement of methylphenidate-induced change in extrastriatal dopamine concentration using [11C]FLB 457 PET.
    Montgomery AJ; Asselin MC; Farde L; Grasby PM
    J Cereb Blood Flow Metab; 2007 Feb; 27(2):369-77. PubMed ID: 16685253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in dopamine availability in the nigrostriatal and mesocortical dopaminergic systems by gait in Parkinson's disease.
    Ouchi Y; Kanno T; Okada H; Yoshikawa E; Futatsubashi M; Nobezawa S; Torizuka T; Tanaka K
    Brain; 2001 Apr; 124(Pt 4):784-92. PubMed ID: 11287377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between psychostimulant-induced "high" and dopamine transporter occupancy.
    Volkow ND; Wang GJ; Fowler JS; Gatley SJ; Ding YS; Logan J; Dewey SL; Hitzemann R; Lieberman J
    Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10388-92. PubMed ID: 8816810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.